1628-19-9 Usage
General Description
1-(4-Chlorophenyl)-2,5-pyrrolidinedione, also known as chlormezanone, is a chemical compound with sedative and muscle relaxant properties. It is commonly used as a medication to treat muscle spasms and tension, as well as anxiety and certain types of pain. Chlormezanone works by affecting the central nervous system to produce a calming effect and reduce muscle tension. It is typically administered orally and is well-absorbed by the body, with effects lasting for several hours. However, it is important to note that chlormezanone can cause drowsiness and impair motor skills, so it should be used with caution and under the guidance of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 1628-19-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,2 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1628-19:
(6*1)+(5*6)+(4*2)+(3*8)+(2*1)+(1*9)=79
79 % 10 = 9
So 1628-19-9 is a valid CAS Registry Number.
1628-19-9Relevant articles and documents
Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones
Kamiński, Krzysztof,Obniska, Jolanta,Chlebek, Iwona,Wiklik, Beata,Rzepka, Sabina
, p. 6821 - 6830 (2013)
The synthesis and anticonvulsant properties of new N-Mannich bases of 3-phenyl- (9a-d), 3-(2-chlorophenyl)- (10a-d), 3-(3-chlorophenyl)- (11a-d) and 3-(4-chlorophenyl)-pyrrolidine-2,5-diones (12a-d) were described. The key synthetic strategies involve the
Synthesis and anticonvulsant properties of new mannich bases derived from 3-aryl-pyrrolidine-2,5-diones. Part 1
Obniska, Jolanta,Kopytko, Maciej,Zagorska, Agnieszka,Chlebek, Iwona,Kaminski, Krzysztof
scheme or table, p. 333 - 341 (2011/07/30)
A series of new Mannich bases of N-[(4-arylpiperazin-1-yl)-methyl]-3- (chlorophenyl)-pyrrolidine-2,5-diones 10-23 have been synthesized and evaluated for their anticonvulsant activity in maximum electroshock (MES) and subcutaneous pentylenetetrazole (scPT
